Latest News

CMS proposal to level E/M payments raises concerns


 


The Community Oncology Alliance made a similar observation.

“CMS is proposing to drastically cut payment for the critical evaluation and management of more complex cancer cases from $172 to $135 (a 22% payment cut) for a new patient and from $148 to $93 (a 37% payment cut) for an existing patient. Although CMS is proposing to streamline the reporting of these cases, the proposal severely undervalues the thorough and critical evaluation and management of seniors with cancer, especially life-threatening complex cases,” the organization said in a statement.

Dr. Worthing said the proposal has implications for recruiting medical trainees into rheumatology and for physicians in practice who may be considering whether to stop seeing Medicare patients. “Since we already have a shortage of rheumatologists in the U.S. that, per the ACR’s recent study, appears to be worsening, we are pretty concerned that if this proposal is finalized, we could be facing a situation with longer wait times to see a rheumatologist,” he said.

But Dr. Worthing praised the proposed reduction of documentation and said that it could save physicians some time. “If this proposal were finalized, I might be able to spend a minute or two less typing or documenting in a typical patient visit,” he said. “That might add up over time to seeing more patients.”

Seema Verma CMS administrator

Seema Verma

CMS officials estimate the proposal would save a lot more time. CMS Administrator Seema Verma said that the documentation change would result in an additional 51 hours for patient care per clinician per year.

However, Dr. Worthing said he was doubtful that any increase in volume would offset the losses from the proposed flat payment across levels 2-5 E/M visits, especially if the pay decrease results in access issues. “If doctors were seeing less and having a harder time covering their business expenses seeing Medicare patients, they might be incentivized to see more commercially insured patients and maintain their practice’s viability that way and not participate in Medicare anymore,” he said.

***This story was updated 8/8/2018.

SOURCE: CMS proposed rule, CMS-1693-P.

Pages

Recommended Reading

Blood pressure meds cut cognitive impairment risk
MDedge Hematology and Oncology
CMS proposes site-neutral payments for hospital outpatient setting
MDedge Hematology and Oncology
CMS to resume risk adjustment payments for 2017
MDedge Hematology and Oncology
CMS targets Part B drug policy in 2019 regulatory updates
MDedge Hematology and Oncology
To tame prescription prices, HHS dips a toe into drug importation stream
MDedge Hematology and Oncology
Keeping the doctor-patient relationship at the office
MDedge Hematology and Oncology
E-cigarettes: Prices down, sales up
MDedge Hematology and Oncology
Lay health workers improve end-of-life care
MDedge Hematology and Oncology
PhRMA spending leads health-sector lobbying efforts
MDedge Hematology and Oncology
Insurance is a matter of life or death for lymphoma patients
MDedge Hematology and Oncology